Biotransformation of hydroxychloroquine to evaluate the cytotoxicity of its metabolites and mimic mammalian metabolism

Asha, 2009, Cunninghamella – a microbial model for drug metabolism studies – a review, Biotechnol. Adv., 27, 16, 10.1016/j.biotechadv.2008.07.005 Boaventura, 2004, Microorganisms as tools in modern chemistry: the biotransformation of 3-indolylacetonitrile and tryptamine by fungi, Brazilian J. Microbiol., 345, 10.1590/S1517-83822004000300014 Clark, 1993, Hydroxychloroquine compared with placebo in rheumatoid arthritis, Ann. Intern. Med., 119, 1067, 10.7326/0003-4819-119-11-199312010-00002 Faber, 2004, 1953 Faber, 1999, Biotransformations Fasinu, 2012, Liver-based in vitro technologies for drug biotransformation studies – a review, Curr. Drug Metab., 13, 215, 10.2174/138920012798918426 Fox, 1993, Mechanism of action of hydroxychloroquine as an antirheumatic drug, Semin. Arthritis Rheum., 23, 82, 10.1016/S0049-0172(10)80012-5 Ibrahim, 2010, Microbial metabolism of cannflavin A and B isolated from Cannabis sativa, Phytochemistry, 71, 1014, 10.1016/j.phytochem.2010.02.011 Kebamo, 2015, The role of biotransformation in drug discovery and development, J. Drug Metab. Toxicol., 06, 10.4172/2157-7609.1000196 Kelly, 2013, Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?, Philos. Trans. R. Soc. B Biol. Sci., 368, 20120476, 10.1098/rstb.2012.0476 Kim, 2006, Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes, Clin. Exp. Immunol., 144, 503, 10.1111/j.1365-2249.2006.03070.x Legrand, 1998, Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients, Blood, 91, 4480, 10.1182/blood.V91.12.4480 Liu, 2020, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov., 6, 16, 10.1038/s41421-020-0156-0 McChesney, 1983, Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate, Am. J. Med., 75, 11, 10.1016/0002-9343(83)91265-2 Njuguna, 2012, Identification and characterization of reactive metabolites in natural products-driven drug discovery, J. Nat. Prod., 75, 507, 10.1021/np200786j Paludo, 2017, Inactivation of β-lapachone cytotoxicity by filamentous fungi that mimic the human blood metabolism, Eur. J. Drug Metab. Pharmacokinet., 42, 213, 10.1007/s13318-016-0337-2 Plantone, 2018, Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review, Clin. Drug Investig., 38, 653, 10.1007/s40261-018-0656-y Ramser, 2009, Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts, J. Invest. Dermatol., 129, 2419, 10.1038/jid.2009.80 Rendic, 2021, Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects, Arch. Toxicol., 95, 1535, 10.1007/s00204-021-03025-z Sibov, T.T., Aya, L., Miyaki, M., Mamani, J.B., Marti, L.C., Sardinha, L.R., Pavon, L.F., Oliveira, D.M. De, Cardenas, W.H., Gamarra, L.F., 2012. Avaliação da marcação de células-tronco mesenquimais de cordão umbilical com nanopartículas superparamagnéticas de óxido de ferro recobertas com Dextran e complexadas a Poli-L-Lisina. Einstein (São Paulo) [online] 10, 180–188. Silva, 2014, Cytotoxicity of lapachol metabolites produced by probiotics, Lett. Appl. Microbiol., 59, 108, 10.1111/lam.12251 Silva, 2016, Microbial metabolism of atovaquone and cytotoxicity of the produced phase I metabolite, Eur. J. Drug Metab. Pharmacokinet., 41, 645, 10.1007/s13318-015-0294-1 Stokkermans, T.J., Goyal, A., Bansal, P., Trichonas, G., 2022. Chloroquine and hydroxychloroquine toxicity [WWW Document]. StatPearls. URL https://www.ncbi.nlm.nih.gov/books/NBK537086/ (accessed 2.14.22). Tran, 2011, Trypan blue dye enters viable cells incubated with the pore-forming toxin HlyII of Bacillus cereus, PLoS One, 6, e22876, 10.1371/journal.pone.0022876 Vichai, 2006, Sulforhodamine B colorimetric assay for cytotoxicity screening, Nat. Protoc., 1, 1112, 10.1038/nprot.2006.179 Vincent, 2005, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol. J., 2, 69, 10.1186/1743-422X-2-69 White, 1996, The treatment of malaria, N. Engl. J. Med., 335, 800, 10.1056/NEJM199609123351107